Litcius/Paper detail

IDEAL Phase 2a Results

Yalini Vigneswaran, Mustafa Hussain, M Alyssa Varsanik, Chase Corvin, Lawrence J. Gottlieb, John C. Alverdy

2024Annals of Surgery10 citationsDOIOpen Access PDF

Abstract

OBJECTIVE: To report the developmental phase results of posterior rectus sheath hiatal flap augmentation (PoRSHA), a promising surgical innovation for large and recurrent paraesophageal hernias. BACKGROUND: Durable hernia repair for large paraesophageal hernias continues to be a surgical challenge. PoRSHA addresses the challenges of current and historical approaches to complex paraesophageal hernias and demonstrates significant promise as a successful alternative approach. METHODS: Using the IDEAL framework, we outline the technical modifications made over the first 27 consecutive cases using PoRSHA. Outcomes measured included hernia recurrence on routine imaging at 6 months and 2 years, development of a postoperative abdominal wall eventration and incidence of solid food dysphagia. RESULTS: Twenty-seven patients at our single institution with type III (n=12), type IV (n=7), or recurrent (n=8) paraesophageal hernias underwent PoRSHA. Surgery was safely and successfully carried out in all cases. Stability of the technique was reached after 16 cases, resulting in 4 main repair types. At an average follow-up of 11 months, we observed no radiologic recurrences, no abdominal eventrations or hernias at the donor site, and 1 patient with occasional solid food dysphagia that resolved with dilation. CONCLUSIONS: PoRSHA can not only be safely added to conventional hiatal hernia repair with appropriate training but also demonstrates excellent short-term outcomes. While the long-term durability with 5-year follow-up is still needed, here we provide cautious optimism that PoRSHA may represent a novel solution to the long-standing high recurrence rates observed with current complex PEH repair.

Topics & Concepts

MedicineHerniaSurgeryDysphagiaHiatal herniaHernia repairAbdominal wallGeneral surgeryRefluxInternal medicineDiseaseGastroesophageal reflux and treatmentsEsophageal and GI PathologyEsophageal Cancer Research and Treatment
IDEAL Phase 2a Results | Litcius